Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Dr. Martens kicks off listed status with 22% earnings rise

Published 17/06/2021, 07:24
Updated 17/06/2021, 07:30
© Reuters. FILE PHOTO: A pair of Dr. Martens boots in London, Britain, September 17, 2020. REUTERS/Simon Newman/File Photo

© Reuters. FILE PHOTO: A pair of Dr. Martens boots in London, Britain, September 17, 2020. REUTERS/Simon Newman/File Photo

LONDON (Reuters) -Dr. Martens, the classic British boot brand that listed its shares in January, on Thursday reported a 22% rise in annual core earnings with online sales helping to soften the hit from COVID-19-related store closures.

The group, known for its chunky boots with yellow stitching, made earnings before interest, tax, depreciation and amortisation (EBITDA) of 224.2 million pounds ($313.6 million) in the year to March 31, on revenue up 15% to 773 million pounds - in line with guidance set out at the time of its initial public offering (IPO) of growth of 14-15%.

Dr. Martens said trading since the year end had been in line with its expectations and it maintained a target of "high teens" percentage revenue growth in 2021-22, as the impact of the COVID-19 pandemic on the group and its markets reduces.

From 2022-23 and over the medium term the group anticipates "mid-teens" revenue growth.

It is targeting e-commerce to grow to 40% of the overall sales mix from 30% in 2020-21, with total direct to consumer (DTC) channels, including retail stores, making up 60% of the mix.

The group said its medium term target of a 30% EBITDA margin was also unchanged.

It expects to begin paying a dividend in the 2021-22 year.

© Reuters. FILE PHOTO: A pair of Dr. Martens boots in London, Britain, September 17, 2020. REUTERS/Simon Newman/File Photo

Dr. Martens' shares have performed strongly since listing at 370 pence in January. They closed Wednesday at 495 pence, valuing the business at 5 billion pounds.

($1 = 0.7149 pounds)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.